podcasts
Podcast: Realizing the promise of precision oncology: a conversation with Andrea Stevens and Clare Jones
June 17, 2026
Precision medicine
In this episode of Within Reach, we confront the truth that precision oncology is advancing faster than our ability to deliver it equitably. Host Evan Young sits down with Clare Jones of Avalere Health and Andrea Stevens of the Precision Cancer Consortium to unpack the global bottlenecks – cost, reimbursement, infrastructure, and education – and chart a path from fragmented biomarker testing to comprehensive, life-extending cancer care that every patient can access.
When we talk about precision oncology, we usually talk about breakthroughs. But behind every advancement in targeted therapies and genomic profiling lies a quieter reality: Most patients in the world still can’t reliably access the tests that unlock these headline treatments.
This week on Within Reach, Clare Jones and Andrea Stevens expose the real bottlenecks – cost and reimbursement, fragmented infrastructure, uneven education, and policy blind spots – and explain why single-gene testing is no longer good enough. Together, they map out what it will take to move from isolated success stories, to a future where tailored cancer care is the standard, not the exception.
Chapters:
0:00 – The promise of precision oncology
5:00 – The cost of testing
15:25 – Global access gaps
20:05 – How therapies drive clinical decisions and the need for education
34:10 – Testing every patient type
41:15 – Designing the future